COAG
Hemab Therapeutics Holdings, Inc. Health Care Biological Products, (No Diagnostic Substances) Russell 3000
$41.45Close
$24.98 – $54.9452-week range
Nov 10, 2026Next report
Highlights
Cautions
- Past its pivot 22.2% above its $33.93 pivot
- Results soon Nov 10, 2026, in 9 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Trade setup
ATR%
6.5%
$2.68 a day · 2×ATR $36.08
RS
—
vs the universe
Trend
—
trend template
Relative volume
1.6×
vs 50-day average
Up/down volume
0.94
50 sessions
Implied move
—
no option chain · report Nov 10, 2026
Contractions
2
51% → 15%
Pivot
$33.93
22.2% above
Volume dry-up
0.9×
10 vs 50 sessions
Screen verdict
Not scorable — no annual report on file.
Last reported
Aug 11, 2026
Results reaction
Aug 11, 2026+8% vs market2 sessions after results
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 11, 2026 | Quarterly ↗ | Jun 30, 2026 | 42d |
| May 21, 2026 | Quarterly ↗ | Mar 31, 2026 | 51d |
Current reports
| Filed | Disclosed |
|---|---|
| Sep 24, 2026 | Director or officer change ↗ |
| Aug 11, 2026 | Results ↗ |
| May 21, 2026 | Results ↗ |
| May 11, 2026 | Director or officer change ↗ |
| May 4, 2026 | Charter or bylaws · Other events ↗ |